We are advancing a broad and diverse pipeline of innovative biologic therapeutic candidates — all generated by our in-house discovery engine — based on our scientific understanding of key biological pathways underlying cancer, retinal diseases and liver and metabolic diseases.

At NGM, innovation is perpetual. Our discovery engine is continually exploring potential new research programs, and our journey to the next great discovery is always underway.